Overview
Bioactive-Tech conducts research and development in biotechnology, transforming ideas into patents and products. The company offers Vitaeapis®, Hemorella®, Hop-RXn™, HopXn+Curcumin and VITAEAPIS® Varminus products, along with consulting, expert assessments, commercial research services and sales of industrial property rights.
Financials
Revenue history (in k)
Filing timeliness
Financial statements were filed on time, on average 28 days early.
- 2025filed
- 202425/06/2025
- 202328/06/2024
- 202213/07/2023
- 202129/06/2022
- 202022/07/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Industry
Offer
- Bee preparations
- Dietary supplements
- Hop preparations
- Curcumin preparations
Website technology
- Website
- WordPress
- Analytics and marketing
- Google Analytics
Trademarks
Bioactive-Tech holds 3 active trademarks registered with the Polish Patent Office. The first mark was filed in 2013.
| Mark | Protected until | |
|---|---|---|
| Mark without a word element(figurative) | Feb 4, 2029 | |
| HEMORELLA(word) | Dec 11, 2028 | |
| VITAEAPIS | Aug 23, 2033 |
Authorized Representatives
Manner of representation
For submitting declarations of will concerning property and non-property rights and obligations and for signing documents on behalf of the company, the following are authorized: a) in the case of a one-person management board, the President of the Management Board independently; b) in the case of a multi-member management board, two members of the management board acting jointly or a member of the management board acting jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Mariusz Gagośage 56 | 95 | $1,283.09 | 95% |
Others | 5 | $67.53 | 5% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2012-09-20.
32 1020 3176 0000 5002 0254 4526- 91 1020 3176 0000 5002 0178 6185
Debt
No entries in the National Debtors Register (KRZ).
Public aid
4 public aid cases recorded, with a total value of $2,573.
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jun 20, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $430$430 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 30, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $430$430 | Prezes Zakładu Ubezpieczeń Społecznych | |
| May 14, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Lublin |
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
 BDO | BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| BioceltixS.A. | $616,315.97 | bioceltix.com | ||
| FamicordtxS.A. | $589,673.84 | famicordtx.com | ||
| VET Cell Techsp. z o.o. | $483,439.81 | vetcelltech.com | ||
| BiottsS.A. | $372,115.60 | biotts.com | ||
| Green ZebrasS.A. | $328,658.91 | whygreenzebras.pl | ||
| Medicofarma BiotechS.A. | $314,882.33 | medicofarmabiotech.pl | ||
| Vitrotest Europesp. z o.o. | $233,350.77 | vitrotest.pl | ||
| TCIsp. z o.o. | $218,471.87 | tci.pl | ||
| Bactremsp. z o.o. | $181,958.36 | bactrem.pl | ||
| Microbe Plussp. z o.o. | $104,197.26 | microbe-plus.com |
Change history
| Date | Event | |
|---|---|---|
| 2018-06-26 | Address change (Radości 4/14, 20-530, Lublin → Al. Wincentego Witosa 3, 20-315, Lublin) | |
| 2018-06-26 | PKD change (Removed: 7 codes; Added: 7 codes) | |
| 2015-10-21 | PKD change (Removed: 31 codes; Added: 10 codes) | |
| 2012-09-07 | Entered in the register |
FAQ
Last updated: 2026-04-23